John Joseph Mclaughlin

Address:

18532 Clark St APT 104, Tarzana, CA 91356

VIN:

1FTKR1EE5APA31164

Make:

FORD

Model:

RANGER

Year:

2010

Address:

17317 Rush Pea Cir, Austin, TX 78738

VIN:

4T1BE46K07U572534

Make:

N/A

Model:

BE46

Year:

2007

US Patent:

6947606, Sep 20, 2005

Filed:

Aug 19, 2002

Appl. No.:

10/224270

Inventors:

John McLaughlin - Los Angeles CA, US

Assignee:

Sony Corporation - Tokyo
Sony Pictures Entertainment, Inc. - Culver City CA

International Classification:

G06K009/36

US Classification:

382246

Abstract:

A process for compressing a two dimensional array of data including at least one array block having a plurality of block rows and a plurality of block columns of pixels, each pixel having at least one associated intensity value. The process includes generating a delta frame associated with a pair of the block columns, the delta frame having a plurality of delta rows and delta columns of delta bits, one of the delta rows being a highest order row; determining a number of duplicate rows of the delta rows, each of the duplicate rows forming an identical row byte value having delta bits which have a predetermined relationship with the delta bits of the highest order row; recording information indicative of the number of duplicate rows; and developing compressed data including the information indicative of the number of duplicate rows of the delta frame.

US Patent:

6947958, Sep 20, 2005

Filed:

Sep 19, 2001

Appl. No.:

09/955820

Inventors:

Alan L. Davidson - Marina Del Rey CA, US
Amit Agrawal - Santa Monica CA, US
James Berney - Yorba Linda CA, US
John McLaughlin - Los Angeles CA, US
Robert Engle - Los Angeles CA, US

Assignee:

Sony Corporation - Tokyo
Sony Electronics Inc. - Park Ridge NJ

International Classification:

G06F017/00

US Classification:

707203, 7071041, 707707, 707 3

Abstract:

A process is provided for documenting the contents of at least one version of a plurality of data products stored in a database, at least one of the products being a composite product having at least a portion of at least one of the data products included therein. The process includes the steps of: creating a state file to be associated with a version of a composite product to be created, the state file specifying a selected version of at least one selected data product to be used in creating the composite product; using the state file to access the selected version of the selected product from the database; creating the version of the composite product by including therein at least a portion of the selected version of the selected product; and generating a state history file associated with the version of the composite product, the state history file indicating that at least a portion of the selected version of the selected product is included within the version of the composite product. The documenting process also includes the steps of: assigning a product name to the composite product; storing the version of the composite product in the database; and storing the state history file in the database. The documenting further includes a step of assigning a version value to the version of the composite product.

US Patent:

7754714, Jul 13, 2010

Filed:

May 18, 2005

Appl. No.:

11/133419

Inventors:

Hui Li - Millbrae CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Vadim M. V. Markovtsov - Foster City CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/48
A61K 31/506

US Classification:

5142358, 51425214, 514275, 544122, 544295, 544323

Abstract:

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

US Patent:

7858633, Dec 28, 2010

Filed:

Dec 6, 2006

Appl. No.:

11/567276

Inventors:

Hui Li - Millbrae CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Mark Markovtsov - Foster City CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/48
A61K 31/506

US Classification:

514275, 544323

Abstract:

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

US Patent:

7868013, Jan 11, 2011

Filed:

Dec 6, 2006

Appl. No.:

11/567506

Inventors:

Hui Li - Millbrae CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Mark Markovtsov - Foster City CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/48
A61K 31/506

US Classification:

514275, 544323

Abstract:

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.

US Patent:

7970549, Jun 28, 2011

Filed:

Aug 28, 2003

Appl. No.:

10/652440

Inventors:

Susan Catalano - Hayward CA, US
John McLaughlin - Stanford CA, US

Assignee:

Rigel Pharmaceuticals Inc. - South San Francisco CA

International Classification:

G01N 33/48
G06G 7/48
C12Q 1/68

US Classification:

702 19, 435 6, 702 13

Abstract:

The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.

US Patent:

8032346, Oct 4, 2011

Filed:

Mar 20, 2007

Appl. No.:

11/726396

Inventors:

Susan Catalano - Hayward CA, US
John McLaughlin - Stanford CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

G06G 7/48
G01N 33/48
G01N 31/00

US Classification:

703 11, 702 19, 702 22

Abstract:

The present invention provides an apparatus, system, method and computer program and computer program product for analyzing cellular samples. One embodiment of the apparatus and method provides a multiparameter assay that provides information with respect to cell proliferation, cell cycling and cell death. The multiparameter assay is particularly useful for assessing and screening candidate compounds for anti-cancer utility.

US Patent:

8410093, Apr 2, 2013

Filed:

Nov 22, 2010

Appl. No.:

12/951949

Inventors:

Hui Li - Millbrae CA, US
Ankush Argade - Foster City CA, US
Rajinder Singh - Belmont CA, US
Sambaiah Thota - Fremont CA, US
David Carroll - San Francisco CA, US
Kin Tso - San Francisco CA, US
Vanessa Taylor - San Francisco CA, US
John McLaughlin - San Francisco CA, US
Vadim Markovtsov - Foster City CA, US

Assignee:

Rigel Pharmaceuticals, Inc. - South San Francisco CA

International Classification:

C07D 239/48
A61K 31/506

US Classification:

5142305, 51425219, 5142522, 514275, 544105, 544295, 544324

Abstract:

The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.